Stanbic doubles cancer treatment support

STANBIC Bank Zimbabwe has doubled its annual donation to the Cancer Association of Zimbabwe (CAZ) for chemotherapy drugs to US$50 000, strengthening a partnership that has supported cancer patients and their families for more than a decade.

The contribution is expected to help patients access treatment as the country continues to grapple with the burden of cancer.

Stanbic Bank head of brand and marketing Tariro Memo said the Standard Bank Group subsidiary considered it a privilege to sustain a partnership built on compassion and a shared commitment to improving the lives of Zimbabweans affected by cancer.

This story is for NewsDay subscribers.